OnDemand WTP Pricing Research

Tag: Premium Pricing Strategy

More Bad News From Apple As iPhone XR Price Slashed | Forbes

More Bad News From Apple As iPhone XR Price Slashed | Forbes

In the short-term, specifically through the rest of this calendar quarter, I don’t expect Apple to implement a direct price cut on the iPhone XR, iPhone XS, or iPhone XS Max to consumers. Although Tim Cook and his team are looking to move to services for more of its income, the “iPhone as a luxury […]

Forbes Healthcare Summit Sparks Conversations About Pricing, Innovation in Pharma | BioSpace

Forbes Healthcare Summit Sparks Conversations About Pricing, Innovation in Pharma | BioSpace

Another point that was raised during the summit was what the future neighborhood drugstore may look like. Larry Murlow, CEO of CVS, said that the retail space of the neighborhood stores will likely be dedicated to other services in the future as it moves to change the healthcare model. Murlow suggested that the future drugstore won’t […]

Could retroactive DIR fees become a thing of the past? | American Pharmacists Association

Could retroactive DIR fees become a thing of the past? | American Pharmacists Association

Under CMS proposed rule, price concessions would be reflected at point of sale APhA and other pharmacy groups hailed a CMS proposed rule that, if finalized, would pass drug price concessions directly to Medicare Advantage (MA) and Part D beneficiaries at the pharmacy counter. The proposed rule would account for pharmacy price concessions, also known […]

Price Transparency at the Point of Care Boosts Patient Savings and Prescriber Efficiency | Business Wire

Price Transparency at the Point of Care Boosts Patient Savings and Prescriber Efficiency | Business Wire

ARLINGTON, Va.–(BUSINESS WIRE)–Surescripts released new data revealing the significant impact of its benefit optimization tools, which have realized measurable cost and time savings for patients and providers. Prescribers utilizing Surescripts Real-Time Prescription Benefit saved patients as much as $8,032 in out-of-pocket costs on a single prescription. Further, when prescribing a medication requiring a prior authorization […]

How price transparency could affect anesthesia practices — 5 takeaways | Becker’s ASC Review

How price transparency could affect anesthesia practices — 5 takeaways | Becker’s ASC Review

As the federal government pushes for increased price transparency, anesthesia practices should prepare to see volume changes at their facilities, according to Anesthesia Business Consultants President and CEO Tony Mira. Here are five takeaways: 1. With patients’ out-of-pocket costs growing, the federal government has made price transparency a top priority. … 4. With this tool, […]

GOP balks at Trump drug pricing plan | TheHill

GOP balks at Trump drug pricing plan | TheHill

Republican opposition is building to a proposal from President Trump to lower drug prices in Medicare. The rare break between Trump and Republican allies follows an aggressive step from the president in October that would tie certain Medicare drug prices to lower prices in other countries, a departure from the traditional GOP position. A coalition of […]

Just What the Doctor Ordered: The Case for Drug Price Controls | Harvard Political Review

Just What the Doctor Ordered: The Case for Drug Price Controls | Harvard Political Review

Unlike many biological diseases, however, this tragic phenomenon has a readily identifiable cause and, potentially, set of cures. When patients who failed to fill out their prescriptions were asked to provide a reason for doing so in a 2017 NPR Health Poll, 67 percent of respondents cited high cost, a number which rose to a staggering […]

Spotlight on drug pricing could be catalyst for change in US biosimilar landscape | Endpoints News

Spotlight on drug pricing could be catalyst for change in US biosimilar landscape | Endpoints News

While biosim­i­lar mak­ers have long es­tab­lished them­selves in Eu­rope, only a few copy­cat ver­sions of bi­o­log­ics have launched in the nascent US mar­ket, which is be­gin­ning to show signs of ma­tur­ing, but is com­pli­cated by a re­im­burse­ment land­scape frac­tured by mul­ti­ple play­ers. The spot­light on drug pric­ing, how­ever, may at long last pro­vide the cat­a­lyst for […]

HHS implements long-awaited 340B drug price transparency rule | Healthcare Finance News

HHS implements long-awaited 340B drug price transparency rule | Healthcare Finance News

The Department of Health and Human Services will implement the long-delayed final rule for enforcing 340B drug ceiling price transparency, on January 1, 2019. The rule directs pharmaceutical manufacturers participating in the 340B drug pricing program to disclose the maximum per unit ceiling price that can be charged to 340B hospitals. Enforcement will be maintained […]

Payless marked up discount shoes to $600 at luxury event ‘Palessi’ | USA Today

Payless marked up discount shoes to $600 at luxury event ‘Palessi’ | USA Today

Troubled discount footwear chain Payless Shoesource may want to change its name. The privately-held Topeka, Kansas-based shoe seller executed the reverse of a bait-and-switch operation recently with a luxury influencer event held in Santa Monica, California. Payless took over a former Armani store, renamed the retail location as “Palessi,” and stocked the outlet with its discount-priced boots, […]